BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 806271)

  • 1. Behaviour of synovial complement C3 and C4 components in inflammatory and degenerative joint diseases, before and after synoviorthesis.
    Gabay R; Micheli A; Fallet GH
    Ann Rheum Dis; 1975 Apr; 34(2):166-70. PubMed ID: 806271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
    Ruddy S; Fearon DT; Austen KF
    Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression of synovial fluid complement activity and rheumatoid factor positivity.
    Hedberg H
    Acta Med Scand; 1970 Nov; 188(5):409-13. PubMed ID: 5490568
    [No Abstract]   [Full Text] [Related]  

  • 5. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the levels of complement components in the synovial fluid in rheumatic diseases.
    Swaak AJ; Van Rooyen A; Planten O; Han H; Hattink O; Hack E
    Clin Rheumatol; 1987 Sep; 6(3):350-7. PubMed ID: 3442962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of immunoglobulins and complement factors in synovial fluid and serum in rheumatoid arthritis, seronegative spondyloarthropathies and osteoarthritis: pathophysiology and retrospective analysis of clinical value].
    Möller B; Kessler U; Braner A; Dielehner N; Kaltwasser JP
    Z Rheumatol; 2002 Feb; 61(1):48-57. PubMed ID: 11974492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.
    Mellbye OJ; Naes B; Munthe E
    Ann Rheum Dis; 1976 Jun; 35(3):233-9. PubMed ID: 825053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
    Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
    Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
    Stojan B; Hasler F
    Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement system in synovial fluids from patients with rheumatoid arthritis.
    Sonozaki H; Torisu M
    Ann Rheum Dis; 1970 Mar; 29(2):164-72. PubMed ID: 4193524
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunopathological changes in rheumatoid arthritis and other joint diseases.
    Ghose T; Woodbury JF; Ahmad S; Stevenson B
    J Clin Pathol; 1975 Feb; 28(2):109-17. PubMed ID: 1092716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic changes in synovial fluid following synovectomy of the knee for rheumatoid arthritis.
    Cracchiolo A; Barnett EV
    J Bone Joint Surg Am; 1969 Apr; 51(3):475-86. PubMed ID: 4180699
    [No Abstract]   [Full Text] [Related]  

  • 14. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B
    Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis.
    Ruddy S; Britton MC; Schur PH; Austen KF
    Ann N Y Acad Sci; 1969 Dec; 168(1):161-72. PubMed ID: 4987687
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A; Whaley K
    J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
    Mollnes TE; Lea T; Mellbye OJ; Pahle J; Grand O; Harboe M
    Arthritis Rheum; 1986 Jun; 29(6):715-21. PubMed ID: 3718564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees.
    Belcher C; Yaqub R; Fawthrop F; Bayliss M; Doherty M
    Ann Rheum Dis; 1997 May; 56(5):299-307. PubMed ID: 9175930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis.
    Spadaro A; Rinaldi T; Riccieri V; Valesini G; Taccari E
    Ann Rheum Dis; 2002 Feb; 61(2):174-6. PubMed ID: 11796407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate.
    Chubinskaya S; Frank BS; Michalska M; Kumar B; Merrihew CA; Thonar EJ; Lenz ME; Otten L; Rueger DC; Block JA
    Arthritis Res Ther; 2006; 8(3):R73. PubMed ID: 16646979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.